Cargando…
Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy
BACKGROUND: Tuberculosis (TB) now ranks alongside HIV as the leading infectious disease cause of death worldwide and incurs a global economic burden of over $12 billion annually. Directly observed therapy (DOT) recommends that TB patients complete the course of treatment under direct observation of...
Autores principales: | McLaren, Zoë M., Milliken, Amanda A., Meyer, Amanda J., Sharp, Alana R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050573/ https://www.ncbi.nlm.nih.gov/pubmed/27716104 http://dx.doi.org/10.1186/s12879-016-1862-y |
Ejemplares similares
-
Ethical aspects of directly observed treatment for tuberculosis: a cross-cultural comparison
por: Sagbakken, Mette, et al.
Publicado: (2013) -
New diagnostics for tuberculosis: fulfilling patient needs first
por: Lemaire, Jean-François, et al.
Publicado: (2010) -
Addressing the policy cacophony does not require more evidence: an argument for reframing obesity as caloric overconsumption
por: Shelley, Jacob J
Publicado: (2012) -
A Data-Driven Evaluation of the Stop TB Global Partnership Strategy of Targeting Key Populations at Greater Risk for Tuberculosis
por: McLaren, Zoë M., et al.
Publicado: (2016) -
Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)